The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan
Introduction: Pulmonary arterial hypertension (PAH) is characterised by endothelial dysfunction and pathological vascular remodelling, resulting in the occlusion of pulmonary arteries and arterioles, right ventricular hypertrophy, and eventually fatal heart failure. Targeting the apelin receptor wit...
Main Authors: | Thomas L. Williams, Duuamene Nyimanu, Rhoda E. Kuc, Richard Foster, Robert C. Glen, Janet J. Maguire, Anthony P. Davenport |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1369489/full |
Similar Items
-
Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands
by: Thomas L. Williams, et al.
Published: (2023-03-01) -
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo
by: Cai Read, et al.
Published: (2021-01-01) -
The Role of Apelin in the Functioning of the Reproductive System
by: A. O. Shpakov, et al.
Published: (2019-07-01) -
The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
by: Yunlu Jiang, et al.
Published: (2021-03-01) -
Apelin and Vasopressin: The Yin and Yang of Water Balance
by: Pierre-Emmanuel Girault-Sotias, et al.
Published: (2021-11-01)